MAITI, Animesh et al. The BRIDGE-DS Study: Improved Glycemic Control and Renal Function in Type 2 Diabetes Mellitus Patients Using the Fixed-Dose Combination of Dapagliflozin and Sitagliptin. Journal of Endocrinology & Metabolism, [S. l.], 2025. DOI: 10.14740/jem1055. Disponível em: https://jem.elmerpub.com/jem/article/view/1528.. Acesso em: 22 may. 2025.